PRXL Share Price

Open 58.62 Change Price %
High 59.28 1 Day 0.20 0.34
Low 58.15 1 Week 0.40 0.69
Close 58.74 1 Month 2.34 4.15
Volume 833602 1 Year -8.03 -12.03
52 Week High 71.13
52 Week Low 51.16
PRXL Important Levels
Resistance 2 59.79
Resistance 1 59.36
Pivot 58.72
Support 1 58.12
Support 2 57.69
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.70 0.20%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
RITT 0.06 -45.45%
More..

PAREXEL International Corporation (NASDAQ: PRXL)

PRXL Technical Analysis 4
As on 2nd Dec 2016 PRXL Share Price closed @ 58.74 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 63.40 & Sell for SHORT-TERM with Stoploss of 63.34 we also expect STOCK to react on Following IMPORTANT LEVELS.
PRXL Target for December
1st Target up-side 64.43
2nd Target up-side 68.24
3rd Target up-side 72.05
1st Target down-side 53.57
2nd Target down-side 49.76
3rd Target down-side 45.95
PRXL Other Details
Segment EQ
Market Capital 1867869184.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.parexel.com
PRXL Address
PRXL
195 West Street
Waltham, MA 02451
United States
Phone: 781-487-9900
Fax: 781-487-0525
Interactive Technical Analysis Chart PAREXEL International Corporation ( PRXL NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on PAREXEL International Corporation
PRXL Business Profile
PAREXEL International Corporation (PAREXEL) is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries. It operates it three segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS) and Perceptive Informatics, Inc. (Perceptive). The Company�s product and service offerings include clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics / outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, post-marketing surveillance. In May 2013, PAREXEL International Corp acquired the entire share capital of HERON Group Ltd.